4.4 Article

Candidate biomarkers in brown adipose tissue for post-mortem diagnosis of fatal hypothermia

Journal

Publisher

SPRINGER
DOI: 10.1007/s00414-022-02897-9

Keywords

Fatal hypothermia; Brown adipose tissue; Proteomics; Biomarkers

Funding

  1. National Natural Science Foundation of China [81971793, 81772023]
  2. Shenyang Science and Technology Innovation Support Plan for Young and Middleage Talent [RC200412]
  3. Innovation and Entrepreneurship Training Program for College Students of China Medical University [X202210159061]
  4. Natural Science Foundation of Liaoning Province [2022-YGJC-74]

Ask authors/readers for more resources

The post-mortem diagnosis of fatal hypothermia (FHT) is challenging, but this study identifies specific proteins in brown adipose tissue (BAT) that can be used as biomarkers for FHT, providing a new strategy for forensic practice.
Post-mortem diagnosis of fatal hypothermia (FHT) is challenging in forensic practice because traditional morphological and biochemical methods lack specificity. Recent studies have reported that brown adipose tissue (BAT) is activated during cold-induced non-shivering thermogenesis in mammals, but BAT has not been used to diagnose FHT. The aim of this study was to identify novel biomarkers in BAT for FHT based on morphological changes and differential protein expression. Two FHT animal models were created by exposing mice to 4 or -20 degrees C at 50% humidity. Morphologically, the unilocular lipid droplet content was significantly increased in BAT of FHT model mice compared with that of control mice. Proteomics analysis revealed a total of 283 and 266 differentially expressed proteins (DEPs) between the 4 or -20 degrees C FHT subgroups and control group, respectively. In addition, 140 proteins were shared between the FHT subgroups. GO and KEGG analyses revealed that the shared DEPs were mainly enriched in pathways associated with metabolism, oxidative phosphorylation, and thermogenesis. Further screening (|log(2)FC| > 1.6, q-value (FDR) < 0.05) identified GMFB, KDM1A, DDX6, RAB1B, SHMT-1, CLPTM1, and LMF1 as candidate biomarkers of FHT. Subsequent validation experiments were performed in FHT model mice using classic immunohistochemistry and western blotting. RAB1B and GMFB expression was further verified in BAT specimens from human cases of FHT. The results demonstrate that BAT can be used as a target organ for FHT diagnosis employing RAB1B and GMFB as biological markers, thus providing a new strategy for the post-mortem diagnosis of FHT in forensic practice.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available